LOADING
Comparing Pfizer Inc (PFE) and AT&T Inc (T) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | PFE | T |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $160.3B | $166.5B |
| P/E Ratio | 37.0 | 8.1 |
| Forward P/E | 9.7 | 9.9 |
| PEG Ratio | 12.89 | 1.53 |
| EPS | $0.76 | $3.02 |
| Revenue Growth (YoY) | 2.6% | 2.3% |
| Profit Margin | 6.8% | 16.9% |
| Return on Equity | 5.0% | 18.3% |
| Dividend Yield | 6.03% | 4.55% |
| Beta | 0.30 | 0.43 |
| 52-Week High | $29.21 | $28.75 |
| 52-Week Low | $22.57 | $19.63 |
| Volume | -- | -- |
AT&T Inc is the larger company by market capitalization. AT&T Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. AT&T Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.